A carregar...

iRECIST: how to do it

BACKGROUND: iRECIST for the objective monitoring of immunotherapies was published by the official RECIST working group in 2017. MAIN BODY: Immune-checkpoint inhibitors represent one of the most important therapy advancements in modern oncology. They are currently used for treatment of multiple malig...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Imaging
Main Authors: Persigehl, Thorsten, Lennartz, Simon, Schwartz, Lawrence H.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6942293/
https://ncbi.nlm.nih.gov/pubmed/31900236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40644-019-0281-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!